SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-24-000009
Filing Date
2024-08-08
Accepted
2024-08-08 16:02:15
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20240630.htm   iXBRL 10-Q 1055983
2 EX-10.1 firstamendmenttoamicuswuxi.htm EX-10.1 29262
3 EX-31.1 fold-06302024xex311.htm EX-31.1 11057
4 EX-31.2 fold-06302024xex312.htm EX-31.2 11133
5 EX-32.1 fold-06302024xex321.htm EX-32.1 8557
  Complete submission text file 0001178879-24-000009.txt   5583238

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20240630.xsd EX-101.SCH 28194
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20240630_cal.xml EX-101.CAL 64749
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20240630_def.xml EX-101.DEF 107434
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20240630_lab.xml EX-101.LAB 506854
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20240630_pre.xml EX-101.PRE 329383
66 EXTRACTED XBRL INSTANCE DOCUMENT fold-20240630_htm.xml XML 793879
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 241188065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)